When Will Small Molecule Lactate Dehydrogenase Inhibitors Realize Their Potential in the Cancer Clinic?
- 19 July 2017
- journal article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 9 (11) , 1113-1115
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lactate Dehydrogenase Inhibition: Biochemical Relevance and Therapeutical PotentialCurrent Medicinal Chemistry, 2019
- Discovery of potent human lactate dehydrogenase A (LDHA) inhibitors with antiproliferative activity against lung cancer cells: virtual screening and biological evaluationMedChemComm, 2017
- Cancer metabolism: a therapeutic perspectiveNature Reviews Clinical Oncology, 2016
- Lactate Dehydrogenase Inhibition: Exploring Possible Applications Beyond Cancer TreatmentFuture Medicinal Chemistry, 2016
- Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer ChemotherapyJournal of Medicinal Chemistry, 2015
- Small-Molecule Inhibitors of Human Ldh5Future Medicinal Chemistry, 2013
- Cancer Cell Metabolism: One Hallmark, Many FacesCancer Discovery, 2012
- Energetics of Normal Cells and Cancer Cells2012
- Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathyClinica Chimica Acta, 1988
- On the Origin of Cancer CellsScience, 1956